CompletedNCT05496504Updated Jun 13, 2023

Pulmonary Hypertension and Arrhythmia

An observational study in Pulmonary Hypertension, sponsored by Asklepios Neurological Clinic Bad Salzhausen. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-06-13.

Sponsored by Asklepios Neurological Clinic Bad Salzhausen · Observational

Study type: Observational
Model: Cohort
Time perspective: Retrospective
Enrollment: 222
Ages: 18 Years and older
Sex: All

Study summary

Patients with pulmonary hypertension underwent (routine) Holter ECG and were screened for (malignant) arrhyhtmias. Results of Holter ECGs were correlated with clinicial and technical data (echocardiography and right heart catheterization).

Conditions studied

Pulmonary Hypertension

Browse trials for

Keywords

pulmonary hypertension
PH
arrhythmias
survival

In context

Hypertension, Pulmonary

1,105 studies on the registry are indexed under Hypertension, Pulmonary; 234 are open to participants now.

This study's enrollment of 222 is above the median of 116 across 386 observational studies indexed under Hypertension, Pulmonary.

Browse Hypertension, Pulmonary studies →

Lead sponsor

Asklepios Neurological Clinic Bad Salzhausen is the lead sponsor of 6 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 18 Years and older
Sexes eligible: All
Accepts healthy volunteers: No
Sampling method: Non-probability sample

Study population

Patients with PH of all groups

Eligibility criteria

Inclusion Criteria: Holter ECG -

Exclusion Criteria: None

Study design

Observational model: Cohort
Time perspective: Retrospective
Enrollment: 222 participants (actual)
Patient registry: No

Interventions

OtherHolter ECG

What researchers measure

Primary outcomes

Arrhythmias during Holter ECG
Which kind of arrhythmias could be detected during repetitive Holter ECG in patients with PH?
Time frame: 1-3 day(s)

Secondary outcomes

Relation between arrhythmias and PH group, echocardiographic data, right heart catheterization data.
Time frame: 1-3 day(s)

Study locations

No study locations are listed for this record.

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

Updates

Tracking since Sep 25, 2026

No changes since tracking began. The registry record was last updated on Jun 13, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT05496504
Lead sponsor: Asklepios Neurological Clinic Bad Salzhausen
Collaborators: University of Giessen
Responsible party: Sponsor
First posted: Aug 11, 2022
Start date: Sep 1, 2013
Primary completion: Dec 31, 2015
Completion: Dec 31, 2015
Last update: Jun 13, 2023

Oversight

Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Hypertension, Pulmonary→

Other studies from this sponsor

Asklepios Neurological Clinic Bad Salzhausen

Start the discussion